3 most recent filings and news items mentioning SILO. Updated every 60 seconds.
OfferingJul 10, 2026Neutral
Silo Pharma filed a Form 8-K disclosing a pre-funded common stock warrant. This agreement allows the holder to purchase shares at a specified price under a securities purchase agreement.
View filing at SEC.gov →
RegulatoryJun 18, 2026Positive
Silo Pharma announced it regained compliance with Nasdaq's minimum closing bid price requirement as of June 17, 2026, resolving a listing qualification matter. The company continues trading on the Nasdaq Capital Market while advancing its lead PTSD drug candidate SPC-15 toward cl
View filing at SEC.gov →
RestructuringJun 3, 2026Negative
Silo Pharma, Inc. filed a Certificate of Change to reduce authorized common shares from 100 million to 6.67 million through a 15-for-1 reverse stock split, with fractional shares rounded up. The restructuring is a common defensive measure to maintain exchange listing compliance a
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.